Title

Phase 1 Trial of Vamorolone, a First-in-Class Steroid, Shows Improvements in Side Effects via Biomarkers Bridged to Clinical Outcomes.

Document Type

Journal Article

Publication Date

6-1-2018

Journal

Steroids

Volume

134

Inclusive Pages

43-52

DOI

10.1016/j.steroids.2018.02.010

Keywords

Adult; Biomarkers; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Pregnadienediols; Quality of Life; Safety; Treatment Outcome; Young Adult

Peer Reviewed

1

This document is currently not available here.

Share

COinS